NRSNW · Insider Trading
NeuroSense Therapeutics Ltd. Warrant
Every open-market purchase and sale reported by NRSNW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Or Eisenberg | Chief Financial Officer | Buy | +250,000 | +$200.00K |
| 2026-06-17 | Alon Ben-Noon | Chief Executive Officer | Buy | +250,000 | +$200.00K |
| 2026-04-01 | Or Eisenberg | Chief Financial Officer | A | +200,000 | — |
| 2026-03-30 | Niva Russek-Blum | Chief Technology Officer | A | +200,000 | — |
| 2026-03-30 | Hagit Binder | General Manager | A | +200,000 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Alon Ben-Noon | Chief Executive Officer | 4,534,233 | $25.39K |
| Or Eisenberg | Chief Financial Officer | 1,504,050 | $8.42K |
| Hagit Binder | General Manager | 521,806 | $2.92K |
| Niva Russek-Blum | Chief Technology Officer | 467,953 | $2.62K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NRSNW quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.